Watch for Eysuvis and Other Steroid Drops for Dry Eyes
Rx Eysuvis (loteprednol 0.25% suspension) will be the first FDA-approved ophthalmic corticosteroid for treating dry eyes.
But it’s only for up to 2 weeks of use.
We know long-term use of any ophthalmic steroid can increase the risk of glaucoma or cataracts...regardless of the steroid, strength, or formulation.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote